ERBB2 and breast carcinoma: Another study showed that the inhibition of the β1 integrin activity by monoclonal antibody AIIB2 markedly promotes radiotherapy efficacy and elevates sensitivity to HER2‐targeting agents of breast cancer cells.265, 266